Principal
investigator
Research interests
This group is interested in understanding disease mechanisms and developing novel
therapeutic strategies for neurodegenerative disorders such as Alzheimer's, Parkinson's
and Huntington's disease, stroke and epilepsy. Key research areas in the lab include
gene therapy and vaccine/antibody-based therapeutic approaches, understanding how
environment affects brain structure and function, developing neurodegenerative disease
models and optimising viral vector-mediated gene transfer technology.
The research
covers the full spectrum from molecular biology through to animal behaviour, with the aim being to advance promising approaches to human clinical trials.
Gene therapy
